Literature DB >> 1466969

An update on vaccine adjuvants in clinical trial.

R Edelman1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1466969     DOI： 10.1089/aid.1992.8.1409

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  3 in total

Review 1.  Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.

Authors:  Nikolai Petrovsky
Journal:  Vaccine       Date:  2006-04-12       Impact factor: 3.641

2.  Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.

Authors:  G H Lowell; R W Kaminski; S Grate; R E Hunt; C Charney; S Zimmer; C Colleton
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

Review 3.  β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19).

Authors:  Alfredo Córdova-Martínez; Alberto Caballero-García; Enrique Roche; David C Noriega
Journal:  Int J Environ Res Public Health       Date:  2021-11-30       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.